Inventor
KRAUSE HANS-JUERGEN
DE34 patents
⚠️ This page may combine multiple inventors who share the name “KRAUSE HANS-JUERGEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE BIOTECHNOLOGY LTD
23 patentsUS9114166B2Aug 25, 2015
Formulation of human antibodies for treating TNF-α associated disorders
ABBVIE BIOTECHNOLOGY LTD67 citations99
US8916157B2Dec 23, 2014
Formulation of human antibodies for treating TNF-α associated disorders
ABBVIE BIOTECHNOLOGY LTD91 citations99
US9738714B2Aug 22, 2017
Formulation of human antibodies for treating TNF-alpha associated disorders
ABBVIE BIOTECHNOLOGY LTD22 citations98
US9272041B2Mar 1, 2016
Formulation of human antibodies for treating TNF-alpha associated disorders
ABBVIE BIOTECHNOLOGY LTD30 citations98
US8802101B2Aug 12, 2014
Formulation of human antibodies for treating TNF-α associated disorders
ABBVIE BIOTECHNOLOGY LTD35 citations98
US9327032B2May 3, 2016
Formulation of human antibodies for treating TNF-alpha associated disorders
ABBVIE BIOTECHNOLOGY LTD17 citations96
US9302011B2Apr 5, 2016
Formulation of human antibodies for treating TNF-α associated disorders
ABBVIE BIOTECHNOLOGY LTD17 citations96
US9295725B2Mar 29, 2016
Formulation of human antibodies for treating TNF-alpha associated disorders
ABBVIE BIOTECHNOLOGY LTD17 citations96
US9289497B2Mar 22, 2016
Formulation of human antibodies for treating TNF-alpha associated disorders
ABBVIE BIOTECHNOLOGY LTD17 citations96
US9272042B2Mar 1, 2016
Formulation of human antibodies for treating TNF-alpha associated disorders
ABBVIE BIOTECHNOLOGY LTD17 citations96
US9220781B2Dec 29, 2015
Formulation of human antibodies for treating TNF-alpha associated disorders
ABBVIE BIOTECHNOLOGY LTD19 citations96
US9085619B2Jul 21, 2015
Anti-TNF antibody formulations
ABBVIE BIOTECHNOLOGY LTD83 citations96
US8940305B2Jan 27, 2015
Formulation of human antibodies for treating TNF-α associated disorders
ABBVIE BIOTECHNOLOGY LTD27 citations96
US8916158B2Dec 23, 2014
Formulation of human antibodies for treating TNF-α associated disorders
ABBVIE BIOTECHNOLOGY LTD31 citations96
US8911741B2Dec 16, 2014
Formulation of human antibodies for treating TNF-alpha associated disorders
ABBVIE BIOTECHNOLOGY LTD26 citations96
US8802102B2Aug 12, 2014
Formulation of human antibodies for treating TNF-α associated disorders
ABBVIE BIOTECHNOLOGY LTD26 citations96
US8795670B2Aug 5, 2014
Formulation of human antibodies for treating TNF-alpha associated disorders
ABBVIE BIOTECHNOLOGY LTD27 citations96
US9950066B2Apr 24, 2018
Formulation of human antibodies for treating TNF-alpha associated disorders
ABBVIE BIOTECHNOLOGY LTD8 citations92
US9750808B2Sep 5, 2017
Formulation of human antibodies for treating TNF-alpha associated disorders
ABBVIE BIOTECHNOLOGY LTD10 citations92
US9732152B2Aug 15, 2017
Formulation of human antibodies for treating TNF-alpha associated disorders
ABBVIE BIOTECHNOLOGY LTD8 citations92
US8772458B2Jul 8, 2014
Crystalline anti-hTNFalpha antibodies
ABBVIE BIOTECHNOLOGY LTD1 citations62
US11191834B2Dec 7, 2021
Protein formulations and methods of making same
ABBVIE BIOTECHNOLOGY LTD0 citations61
US11167030B2Nov 9, 2021
Protein formulations and methods of making same
ABBVIE BIOTECHNOLOGY LTD0 citations61